Gaia Cattadori

ORCID: 0000-0002-0954-9871
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiovascular and exercise physiology
  • Heart Failure Treatment and Management
  • Cardiovascular Function and Risk Factors
  • Hemodynamic Monitoring and Therapy
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Heart Rate Variability and Autonomic Control
  • Cardiac pacing and defibrillation studies
  • Cardiovascular Effects of Exercise
  • Cardiac Imaging and Diagnostics
  • Mechanical Circulatory Support Devices
  • Cardiac Health and Mental Health
  • Cardiac Valve Diseases and Treatments
  • Atrial Fibrillation Management and Outcomes
  • Diabetes Treatment and Management
  • Erythropoietin and Anemia Treatment
  • Cardiac Arrest and Resuscitation
  • High Altitude and Hypoxia
  • Cardiac, Anesthesia and Surgical Outcomes
  • Cardiac Arrhythmias and Treatments
  • Potassium and Related Disorders
  • Cardiac Structural Anomalies and Repair
  • Cardiac electrophysiology and arrhythmias
  • Respiratory Support and Mechanisms
  • Stroke Rehabilitation and Recovery
  • Sepsis Diagnosis and Treatment

Centro Cardiologico Monzino
2009-2024

Istituti di Ricovero e Cura a Carattere Scientifico
2012-2024

MultiMedica
2016-2024

University of Milan
1998-2024

Mylan (Switzerland)
2022-2024

Istituti Clinici Scientifici Maugeri
2022

Foundation of Cardiac Surgery Development
2022

Ospedale San Giuseppe
2016

Scuola Superiore Sant'Anna
2016

Fondazione Salvatore Maugeri
2013

Alveolar gas diffusion (DLCO) is impaired in chronic heart failure (CHF). Diffusion depends on membrane (DM) and the amount of blood participating exchange (VC). How DM, VC, alveolar-capillary unit behave relationship to CHF severity unknown.We measured pulmonary function, including DLCO, alveolar volume (VA), 191 patients NYHA class I-III. were grouped accordingly peak exercise oxygen uptake (pVO(2)): group <12 mL/min/kg (n=24), 12-16 (n=76), 16-20 (n=64), >20 (n=27). VA lowest severe...

10.1093/eurheartj/ehl302 article EN European Heart Journal 2006-09-25

We investigated the association between 9 polymorphisms of genes encoding hemostasis factors and myocardial infarction in a large sample young patients chosen because they have less coronary atherosclerosis than older patients, thus their disease is more likely to be related genetic predisposition prothrombotic state.This nationwide case-control study involved 1210 who had survived first at an age <45 years underwent arteriography 125 care units healthy subjects matched for age, sex,...

10.1161/01.cir.0000051465.94572.d0 article EN Circulation 2003-03-03

In patients with heart failure (HF), during maximal cardiopulmonary exercise test, anaerobic threshold (AT) is not always identified. We evaluated whether this finding has a prognostic meaning.We recruited and prospectively followed up, in 14 dedicated HF units, 3058 systolic (left ventricular ejection fraction <40%) stable clinical conditions, New York Heart Association class I to III, who underwent clinical, laboratory, echocardiographic, test investigations at study enrollment. excluded...

10.1161/circheartfailure.113.000471 article EN Circulation Heart Failure 2013-07-24

In heart failure (HF) patients, exercise may increase pulmonary capillary hydrostatic pressure and thereby generate edema. If edema developed, alveolar-capillary membrane conductance (Dm), measured immediately after exercise, would decrease. To test this hypothesis, we Dm before at 2 60 minutes exercise.We studied 10 HF patients with exercise-induced periodic breathing, peak o2 < or =15 mL x min(-1) kg(-1) (severe HF), o2=15 to 20 (moderate normal subjects (control). Using the...

10.1161/01.cir.0000097115.61309.59 article EN Circulation 2003-10-28

Aims To evaluate whether anti-aldosteronic treatment influences lung diffusion (DLCO) in chronic heart failure (HF) patients. Spironolactone improves clinical conditions and prognosis HF reduces connective tissue matrix turnover; DLCO abnormalities are related to increase fibrosis derangement. Methods results Thirty stable patients, with reduced (<80% of predicted), were randomly assigned active (25 mg spironolactone daily) or placebo addition conventional anti-failure treatment. They...

10.1093/eurheartj/ehi023 article EN European Heart Journal 2004-12-08

To assess the effect of chronotropic incompetence on functional capacity in chronic heart failure (CHF) patients, as evaluated NYHA and peak oxygen consumption (pVO(2) ), focusing presence dose β-blocker treatment.Nine hundred sixty-seven consecutive CHF patients were evaluated, 328 whom discarded because they failed to meet study criteria. Of 639 analyzed, 90 not treated with β-blockers whereas other 549 were. The latter further subdivided high (n = 184) low 365) daily group accordance an...

10.1111/j.1755-5922.2010.00184.x article EN Cardiovascular Therapeutics 2010-06-11

Abstract Aims Ventilation vs. carbon dioxide production (VE/VCO 2 ) is among the strongest cardiopulmonary exercise testing prognostic parameters in heart failure (HF). It usually reported as an absolute value. The current definition of normal VE/VCO slope values inadequate, since it was built from small groups subjects with a particularly limited number women and elderly. We aimed to define prediction formulas sizable population test whether power HF different if expressed percentage...

10.1002/ehf2.12582 article EN cc-by-nc ESC Heart Failure 2020-01-01
Coming Soon ...